From PsychonautWiki
Jump to navigation Jump to search

This page has not been approved by the PsychonautWiki administrators.

It may contain incorrect information, particularly with respect to dosage, duration, subjective effects, toxicity and other risks.

Summary sheet: BOD
Chemical Nomenclature
Common names BOD
Substitutive name 4-methyl-2,5,beta-trimethoxyphenethylamine
Systematic name 2-(2,5-Dimethoxy-4-methylphenyl)-2-methoxyethan-1-amine
Class Membership
Psychoactive class Psychedelic
Chemical class Phenethylamine
Routes of Administration

WARNING: Always start with lower doses due to differences between individual body weight, tolerance, metabolism, and personal sensitivity. See responsible use section.

DISCLAIMER: PW's dosage information is gathered from users and resources for educational purposes only. It is not a recommendation and should be verified with other sources for accuracy.

4-methyl-2,5,beta-trimethoxyphenethylamine (also known as BOD ) is a lesser-known psychedelic and entactogen substance of the phenethylamine class. BOD is a member of the BOx family of compounds which are relatively unknown, and have only recently found sales in the research chemical community.

BOD was first synthesized and tested by Alexander Shulgin.[1] It gained little popularity and even by 2019 it is still relatively unknown.From the few reports of it, BOD seems to be very much like the DOx family compounds in terms of it being dose sensitive, long lasting, intense, and very stimulating albeit much less potent. However, its chemical structure is related to compounds of the trimethoxyamphetamine class, and it may share a similar pharmacological profile to both.

History and culture

BOD was first synthesized and tested by Alexander Shulgin.[1] It gained little popularity and even by 2019 it is still relatively unknown. In 1991, the synthesis and pharmacology of BOD was published in Shulgin's book PiHKAL ("Phenethylamines I Have Known And Loved").[2]. Since 1991 the substance has occasionally been reported on but very few people had been using it until around 2018-2019.


BOD, or 4-methyl-2,5,beta-trimethoxyphenethylamine is a molecule of the substituted phenethylamine class. BOD was the first BOx compound shulgin studied and it is the beta-methoxy analog of 2cd. Shulgin only looked into 4 BOx compounds of which only BOB and BOD were found to have psychedelic and entacteogenic effects.


Pill bottle-o.png

This pharmacology section is incomplete.

You can help by adding to it.

Subjective effects

Most users describe BOD as being clearheaded and lucid at lower doses, in ways reminiscent of most 2cx's. At higher doses however the experience can become highly intense and in some cases produces unique effects which are not found in other psychedelics. Disclaimer: The effects listed below cite the Subjective Effect Index (SEI), a research literature based on anecdotal reports and the personal experiences of PsychonautWiki contributors. As a result, they should be regarded with a healthy degree of skepticism. It is worth noting that these effects will not necessarily occur in a predictable or reliable manner, although higher doses are more liable to induce the full spectrum of effects. Likewise, adverse effects become much more likely with higher doses and may include addiction, serious injury, or death.

Physical effects

Visual effects

Cognitive effects

Auditory effects

Multi-sensory effects

Transpersonal effects

Experience reports

There are currently 0 experience reports which describe the effects of this substance in our experience index.

Additional experience reports can be found here:

Toxicity and harm potential


This toxicity and harm potential section is a stub.

As a result, it may contain incomplete or even dangerously wrong information. You can help by expanding upon or correcting it.
Note: Always conduct independent research and use harm reduction practices if using this substance.

BOD has had such a limited history of us that as of 2019 while certain individuals are able to use as high as 70mg, and given the reduced potency compared to other long lasting psychedelic it is most likely BOD has a toxicity profile comparable to the 2Cx compounds. However given its strong dose response curve, the little information about the substance, and the long come up. It is strongly recommended that one use harm reduction practices when using this substance.

Lethal dosage

The highest dose consumed of BOD that has been reported so far is around 70mg. BOD has very little likihood of being a full agonist of 5-HT2A but that does not mean it is a purely safe psychedelic. While most dose ranges display common doses at 20-30mg, due to the substances response curve and its slow come up, the dose information currently available may not be correct, as other subtances Shulgin studied he found inactive were actually active at much higher doses.

Tolerance and addiction potential

Dangerous interactions


This dangerous interactions section is a stub.

As such, it may contain incomplete or invalid information. You can help by expanding upon or correcting it.

Although many psychoactive substances are reasonably safe to use on their own, they can suddenly become dangerous or even life-threatening when combined with other substances. The following list includes some known dangerous combinations (although it is not guaranteed to include all of them). Independent research (e.g. Google, DuckDuckGo) should always be conducted to ensure that a combination of two or more substances is safe to consume. Some of the listed interactions have been sourced from TripSit.

Legal status


This legality section is a stub.

As such, it may contain incomplete or wrong information. You can help by expanding it.

  • United States: BOD is currently unscheduled in the United States, however it due to its chemical similarity to 2c-d it may be charged under the federal analog act if being purchased for human consumption.[citation needed]

See also

External links


  • APA formatted reference

Please see the citation formatting guide if you need assistance properly formatting citations.


  1. 1.0 1.1 Shulgin, Alexander (1991). PiHKAL: A Chemical Love Story. Berkeley, CA: Transform Press. pp. 53–56.
  3. Talaie, H., Panahandeh, R., Fayaznouri, M. R., Asadi, Z., & Abdollahi, M. (2009). Dose-independent occurrence of seizure with tramadol. Journal of medical toxicology, 5(2), 63-67. doi:10.1007/BF03161089